AG 55 First Filing Hits: What Life Actuaries Learned

From reviewing the AG 55 text alongside VM-30 requirements and tracking industry comment letters through adoption, the disclosure-only framing in year one was a deliberate compromise that sets the stage for prescriptive reserve guidance in 2027. April 1, 2026 marked the first filing deadline under Actuarial Guideline LV (AG 55), requiring U.S. ceding insurers to submit asset adequacy testing results for offshore reinsurance transactions where the assuming counterparty does not file a VM-30 memorandum with U.S. regulators. The guideline gives regulators new transparency into asset-intensive life reinsurance treaties that previously lacked VM-30 disclosure, and the first round of reports has already surfaced the practical challenges that appointed actuaries, reinsurers, and regulators will need to resolve before the framework matures.

What AG 55 Requires and Why It Exists

AG 55 was adopted by the NAIC Executive Committee and Plenary on August 13, 2025, following votes by the Life Actuarial (A) Task Force on June 5 and the Life Insurance and Annuities (A) Committee on July 14. The guideline addresses a specific regulatory concern: that U.S. life insurers may be entering reinsurance transactions that materially lower the total asset requirement (the sum of reserves and capital) supporting their asset-intensive business, facilitating capital releases that could prejudice policyholder interests.

The core mechanism is straightforward. AG 55 requires ceding insurers to perform cash flow testing (CFT) of the post-reinsurance reserve, evaluating whether assets supporting ceded business remain adequate under moderately adverse conditions. Results must be documented and reported annually by April 1 to the ceding company's domestic regulator. The documentation, sensitivity test results, and attribution analysis are incorporated as a separate, easily identifiable section of the actuarial memorandum required by VM-30, or as a standalone document.

This represents a meaningful expansion of the asset adequacy testing framework. Before AG 55, appointed actuaries at ceding companies were not required to evaluate the adequacy of reserves held by offshore reinsurers that fell outside U.S. regulatory jurisdiction. The guideline closes that gap by requiring the ceding company's own actuarial analysis, regardless of what the assuming reinsurer reports under its home jurisdiction's regulatory framework.

Scope: Which Treaties Are In and Which Are Out

AG 55 applies to asset-intensive reinsurance transactions established on or after January 1, 2016, ceded to counterparties not required to file VM-30 memoranda with U.S. state regulators. This primarily targets offshore reinsurance with jurisdictions like Bermuda, the Cayman Islands, and other offshore financial centers where asset-intensive life reinsurance has concentrated over the past decade.

The NAIC estimates approximately 100 treaties fall within scope for the 2025 year-end reporting cycle. But the guideline's application is not uniform across all offshore reinsurance. AG 55 uses a tiered materiality framework that determines which treaties require full cash flow testing:

Ceded Reserve Threshold	Percentage of Life/Annuity Reserves	Requirement
Exceeds $5 billion	Any percentage	Full CFT required
Exceeds $1 billion	More than 5%	Full CFT required
Exceeds $500 million	More than 10%	Full CFT required
Exceeds $100 million	More than 20%	Full CFT required

These thresholds ensure that the largest and most material offshore cessions receive the most rigorous scrutiny, while smaller treaties face a lighter touch. However, there is an important catch: the appointed actuary can flag additional treaties involving significant counterparty collectability risk regardless of whether they meet the size thresholds. This gives regulators a backstop for situations where the numbers alone do not capture the full risk profile.

Third-Party Treaty Distinctions

AG 55 distinguishes between affiliated and non-affiliated reinsurance. For non-affiliated transactions, the effective date threshold shifts to January 1, 2020, with a hardship exemption available for treaties established between 2016 and 2019, subject to domestic regulator approval. Affiliated transactions (where the cedant holds a 1% or greater ownership stake, or where the reinsurer holds more than 25% of reserves assumed from the ceding company) face the full scope of AG 55 requirements from the 2016 effective date.

This distinction reflects the regulatory reality that affiliated reinsurance, where the ceding company and the assuming reinsurer share common ownership, raises heightened concerns about capital optimization at the expense of reserve adequacy. Private equity-backed life insurers and their affiliated offshore reinsurers are the primary focus here, though the guideline applies regardless of ownership structure.

The Year-One Filing: Disclosure Only, but with Sharp Teeth

In its currently adopted form, AG 55 is a disclosure requirement. It does not prescriptively mandate that additional reserves be posted based on the asset adequacy testing results. This distinction matters enormously for understanding what the first round of filings actually represents.

The disclosure-only framing was a deliberate regulatory choice. During the comment letter period, industry participants argued that prescriptive reserve requirements based on AG 55 analysis would create significant uncertainty and could reduce asset-intensive reinsurance activity. Regulators responded by adopting the disclosure-only approach for year one, with an explicit commitment to reassess after reviewing the first round of reports.

But "disclosure only" does not mean "no consequences." The appointed actuary retains full authority to determine whether additional reserves should be held based on the AG 55 analysis, and the domestic regulator can require additional reserves as deemed necessary. What the disclosure-only framing removes is a prescriptive formula that would automatically trigger reserve increases based on specific quantitative outcomes from the cash flow testing.

From tracking the comment letter process, several themes emerged from industry responses during the adoption period:

Data access concerns: Ceding companies expressed significant uncertainty about their ability to obtain sufficiently detailed information from offshore reinsurers about supporting asset portfolios. Many treaties do not require the reinsurer to provide asset-level data to the cedant.
Interpretation of "moderately adverse": The standard for cash flow testing under AG 55 requires evaluation under "moderately adverse conditions," but actuaries raised questions about how to calibrate these scenarios for offshore reinsurance structures where the asset portfolio characteristics may differ substantially from what U.S.-domiciled companies typically hold.
Treaty amendment risk: Industry participants flagged concern that AG 55 compliance could require amendments to existing reinsurance treaties, particularly around data-sharing provisions and change-in-law clauses, creating uncertainty about the cost and feasibility of compliance for in-force blocks.
Competitive positioning: Some commenters argued that AG 55 could disadvantage U.S. cedants relative to international competitors not subject to equivalent requirements, potentially driving reinsurance activity toward jurisdictions with less regulatory oversight.

How AG 55 Interacts with VM-30 and the PBR Framework

Understanding AG 55 requires placing it within the broader Valuation Manual framework that governs U.S. life insurance reserving. VM-30 establishes the requirements for the actuarial memorandum that appointed actuaries must file with their domestic regulators, including asset adequacy analysis results. AG 53 (Actuarial Guideline LIII), adopted in 2022, introduced uniform asset adequacy testing standards that strengthened the VM-30 ecosystem.

AG 55 extends these principles to a specific class of transactions that previously fell outside the VM-30 disclosure framework: reinsurance ceded to counterparties that do not file VM-30 memoranda with U.S. regulators. The guideline operates within the existing VM-30 infrastructure; AG 55 results are either incorporated into the VM-30 memorandum or filed as a standalone companion document.

For appointed actuaries, this creates a new layer of work within the existing annual statement cycle. The AG 55 analysis must be completed after the December 31 valuation date and filed by April 1, the same deadline that applies to the VM-30 actuarial memorandum. This compressed timeline was one of the most commonly cited implementation challenges in industry comment letters.

The Starting Asset Amount and Attribution Analysis

Two technical components of AG 55 deserve particular attention because they drove significant implementation effort in the first filing cycle.

The Starting Asset Amount is the foundation of the AG 55 cash flow testing analysis. It equals the post-reinsurance reserve, reduced by guideline-excluded assets such as non-admitted assets, letters of credit, and parental guarantees. This calculation forces the appointed actuary to identify exactly what assets back the reinsured liabilities and to strip out forms of support that may not be available under stress scenarios.

The attribution analysis requires companies to bridge the gap between pre-reinsurance and post-reinsurance reserves, attributing changes to specific drivers: discount rates, policyholder behavior assumptions, mortality assumptions, and reserve floor removals. This analysis is where AG 55's transparency objective becomes most concrete. Regulators want to see exactly how much of the reserve reduction attributable to reinsurance comes from legitimate actuarial adjustments versus structural arbitrage between U.S. statutory reserving and offshore regulatory frameworks.

For the year-end 2025 analysis, aggregation was permitted by counterparty. Starting with year-end 2026, separate testing will be required by significant product lines within each counterparty relationship. This phase-in reflects the practical reality that many companies needed the first year to build the modeling infrastructure and data pipelines necessary for more granular analysis.

The Proxy Asset Problem

One of the most challenging implementation issues in the first AG 55 filing cycle involved situations where the ceding company lacks transparency into the assets supporting its ceded reserves. This is not an edge case. Many offshore reinsurance arrangements involve commingled asset pools, and the reinsurance treaty may not require asset-level reporting to the cedant.

AG 55 addresses this through a "conservative proxy asset portfolio and assumption set" standard. When the cedant cannot obtain actual asset data from the reinsurer, the appointed actuary must construct a proxy portfolio using conservative assumptions about asset quality, duration, and credit risk. The standard is designed to ensure that data opacity does not become a mechanism for understating the reserve adequacy challenge.

In practice, this created significant tension during the first filing cycle. Reinsurers operating in jurisdictions like Bermuda maintain that their assets are subject to rigorous oversight by the Bermuda Monetary Authority (BMA), and that providing asset-level detail to every cedant creates operational and confidentiality concerns. Cedant actuaries, meanwhile, need sufficient data to perform credible cash flow testing and are reluctant to rely entirely on proxy assumptions that may overstate or understate the actual risk.

The Similar Memorandum alternative, analyzed in detail by Milliman, offers a potential bridge. If a memorandum similar to VM-30 is available from the assuming reinsurer and the ceding company's domestic regulator can use it to determine asset adequacy, it may serve as an appropriate alternative to independent cash flow testing. A Similar Memorandum must include eleven essential elements: asset descriptions, assumption documentation, methodology, rationale for the degree of rigor, materiality thresholds, asset adequacy criteria, year-over-year changes, results summary, conclusions, AG 53 relevant aspects, and qualified actuary standards.

The Bermuda Dimension: Basis Risk Between Regulatory Frameworks

AG 55 sits at the intersection of two very different regulatory approaches to life insurance reserving. U.S. statutory accounting uses formulaic and principles-based reserves calibrated to specific actuarial standards. Bermuda's Economic Balance Sheet approach, implemented through Technical Provisions, typically produces lower reserves than U.S. methods for comparable blocks of business.

This basis risk is not new, but AG 55 makes it visible for the first time. When a U.S. insurer cedes a block of life or annuity business to a Bermuda reinsurer, the post-reinsurance reserve on the U.S. statutory balance sheet may be lower than it would be if the business remained on the ceding company's books. AG 55 forces the appointed actuary to evaluate whether the assets backing the ceded reserves at the offshore reinsurer are adequate under U.S. standards, not Bermuda standards.

The scale of this issue is substantial. U.S. life insurers ceded approximately $2.4 trillion of reserves in 2024, with more than $1.1 trillion flowing to offshore jurisdictions, predominantly Bermuda. The Bermuda long-term reinsurance sector manages $1.52 trillion in assets and serves approximately 90 million policyholders globally. More than 80 Class E reinsurers now operate on the island, though the pace of new entrants slowed in 2025 as the BMA tightened its regulatory framework.

Bermuda's own regulatory response has been significant. The BMA enacted its CP1/CP2 enhancements in March 2024, with phase-in periods of 3 years for general insurers and 10 years for long-term insurers. These require prior BMA approval for all new block reinsurance involving long-term commercial reinsurers, enhanced model risk management frameworks, and expanded investment portfolio reporting. An April 2025 BMA guidance clarified that both future premiums and in-force business qualify as block transactions subject to enhanced scrutiny.

Despite Bermuda's status as a reciprocal jurisdiction under NAIC standards (which waives certain collateral requirements), U.S. ceding insurers must still comply with AG 55's asset adequacy testing and disclosure provisions. Reciprocal jurisdiction status does not exempt cedants from demonstrating reserve adequacy through their own actuarial analysis.

Deal Activity That Shapes the AG 55 Landscape

The first AG 55 filing cycle coincides with a period of unprecedented transaction volume in asset-intensive life reinsurance. Several landmark deals completed in late 2025 and early 2026 illustrate why regulators view enhanced oversight as necessary:

Corebridge-Venerable transaction (January 2026): approximately $51 billion in account value, described as the largest standalone reinsurance deal in the life sector to date.
Brighthouse Financial acquisition by Aquarian Capital (February 2026): $4.1 billion transaction placing a major U.S. variable annuity book under PE-affiliated ownership.
MetLife-Talcott (December 2025): $10 billion in variable annuity reserves transferred via reinsurance.
Equitable-RGA (July 2025): 75% cession of individual life block, releasing more than $2 billion in deployable capital.
Jackson Financial-TPG partnership: $500 million investment with establishment of Hickory Brooke Reinsurance, a new Michigan-based captive reinsurer.

These transactions collectively represent hundreds of billions in reserves flowing through structures where AG 55 now requires explicit asset adequacy disclosure. The concentration of deal activity among private equity-affiliated counterparties underscores the regulatory motivation behind AG 55: ensuring that capital optimization strategies do not erode the asset backing that policyholders depend on.

Implementation Challenges: What the First Filing Revealed

Patterns observed in the first AG 55 filing cycle point to several recurring challenges that appointed actuaries and their teams encountered.

Data Gaps and Reinsurer Cooperation

The most fundamental challenge was obtaining sufficiently detailed data from offshore reinsurers. While AG 55 requires the ceding company's appointed actuary to perform cash flow testing, the quality of that analysis depends entirely on the information available about the assets backing the ceded reserves. Many existing reinsurance treaties were negotiated before AG 55 was contemplated and do not include data-sharing provisions adequate for the level of analysis the guideline requires.

Companies that needed to negotiate new data-sharing arrangements with their reinsurers faced a compressed timeline. AG 55 was adopted in August 2025 with an effective date of December 31, 2025, giving companies roughly four months to scope their in-scope treaties, negotiate data access, build modeling capabilities, and complete the analysis. The hardship extension provision, which allows companies to submit reports after April 1 with domestic regulator approval, was designed precisely for situations where data access issues prevented timely completion.

Modeling Infrastructure

Cash flow testing of post-reinsurance reserves requires modeling capabilities that many ceding companies had not previously built. For transactions involving coinsurance or modified coinsurance (ModCo) structures with funds withheld, the modeling must capture the interaction between the ceded liabilities and the asset portfolio supporting them, including credit risk, reinvestment risk, and liquidity risk under stress scenarios.

Companies with robust existing CFT infrastructure for their VM-30 analysis could extend their models to accommodate AG 55 requirements with moderate additional effort. Companies that relied more heavily on formulaic or simplified approaches to asset adequacy analysis for their retained business faced a steeper implementation curve.

Cross-Functional Coordination

AG 55 requires collaboration between teams that historically operated in separate workstreams. The actuarial team owns the cash flow testing methodology and assumption development. The investment team understands the asset portfolio characteristics. The reinsurance team manages the counterparty relationship and treaty terms. The legal team navigates data-sharing and change-in-law provisions.

For the first filing, many companies reported that simply assembling the right people and establishing clear ownership of the AG 55 process consumed significant time and management attention. This is a one-time setup cost that should diminish in subsequent years, but it was a meaningful factor in year-one implementation timelines.

Interpretation Variance

Because AG 55 is new and the first filing cycle offered no precedent, companies made different interpretive choices about key provisions. How to define the starting asset amount when treaty structures involve multiple layers of support. What constitutes a "conservative" proxy portfolio when actual asset data is unavailable. How to calibrate "moderately adverse" scenarios for offshore counterparties with different asset allocation profiles than typical U.S. statutory portfolios.

This interpretation variance is expected and was anticipated by regulators. The Life Actuarial Task Force created standardized reporting templates at the NAIC Fall 2025 National Meeting to provide structure around the filing, including fields for details about the assuming company, key risks, supporting assets, assumed net yields, cash flow testing results, and attribution analyses. But templates can standardize format without standardizing judgment, and the first round of reports will inevitably reflect a range of approaches.

What Comes Next: The 2027 Prescriptive Horizon

The NAIC has been explicit that year one is a data-gathering exercise. The Valuation and Analysis (E) Working Group will prioritize review of the first AG 55 reports in the second quarter of 2026, with a goal of sharing initial findings at the NAIC Summer 2026 National Meeting. Based on that review, the Life Actuarial Task Force plans to reassess AG 55 to determine whether changes are needed to the data being collected and whether requirements beyond disclosure should be incorporated.

Several possible trajectories exist for AG 55's evolution:

Prescriptive reserve guidance: If the first round of reports reveals material gaps between pre-reinsurance and post-reinsurance reserves that are not adequately explained by legitimate actuarial adjustments, regulators may introduce quantitative triggers that require additional reserves when the AG 55 analysis identifies a deficiency.
Enhanced data requirements: Regulators may standardize the data that reinsurers must provide to cedants, reducing reliance on proxy asset portfolios and narrowing interpretation variance.
Product-line granularity: The phase-in from counterparty-level aggregation (year one) to product-line-level testing (year two and beyond) will increase the analytical burden but provide regulators with more targeted visibility into which product types are most affected by offshore reinsurance structures.
Integration into the Valuation Manual: Both AG 55 and its predecessor AG 53 are expected to eventually be folded into the Valuation Manual as permanent provisions rather than remaining standalone actuarial guidelines.

Commissioner Godfread, who applauded the adoption of AG 55 at the Summer 2025 meeting, also flagged a broader concern about assets moving to offshore jurisdictions that "don't offer the same transparency or oversight" as reciprocal jurisdictions. He warned that such activity "opens the door to regulatory arbitrage, draws increased scrutiny, and weakens the trust that underpins our financial system." This language suggests that the regulatory trajectory is toward tighter requirements, not looser ones.

The Global Context: Bermuda, the UK, and Asia-Pacific

AG 55 is not happening in isolation. Regulators across multiple jurisdictions are converging on enhanced oversight of asset-intensive reinsurance at roughly the same time.

The UK's Prudential Regulation Authority (PRA) has taken an even more skeptical stance, characterizing funded reinsurance as "often complex, opaque, and increas[ing] interconnections in the financial system" in its July 2025 Financial Stability Report. The PRA has pushed UK cedants to prioritize Matching Adjustment-eligible collateral over illiquid private assets, maintain conservative recapture triggers calibrated to reinsurer solvency ratios, and build springing overcollateralization provisions into treaty terms.

Japan's Financial Services Agency (JFSA) implemented the Japan Insurance Capital Standard (JICS) in 2025, with heightened scrutiny of asset-manager-backed reinsurers. An August 2025 announcement established a new regulatory division specifically for asset management-insurance oversight. Singapore's Monetary Authority (MAS) has been conducting data collection since August 2024, with amendments to Notice 133 refining illiquidity premium treatment.

South Korea announced in January 2026 that the Korean Insurance Capital Standard (K-ICS) will require 50% of required capital from high-quality sources (paid-in capital, retained earnings, Tier 1 instruments) effective January 2027. This directly addresses concerns about the quality of capital supporting reinsurance obligations.

For appointed actuaries at U.S. ceding companies, this global convergence has a practical implication: the reinsurers on the other side of their treaties are simultaneously navigating regulatory changes in their home jurisdictions. A Bermuda reinsurer complying with BMA CP1/CP2 enhancements, a UK cedant managing PRA expectations, and a U.S. ceding company filing under AG 55 are all operating within the same treaty structure. The interaction effects between these parallel regulatory initiatives will shape how asset-intensive reinsurance evolves over the next several years.

Why This Matters for Practicing Actuaries

AG 55 carries specific implications for several actuarial roles:

Appointed actuaries at ceding companies now bear explicit responsibility for evaluating the adequacy of reserves held offshore. This is not a theoretical obligation; it requires building modeling capabilities, negotiating data access with reinsurers, and exercising professional judgment about proxy assumptions when data is unavailable. The actuarial opinion must clearly communicate the AG 55 findings to the domestic regulator.

Valuation actuaries need to integrate AG 55 analysis into the annual statement cycle without disrupting existing VM-30 workflows. The April 1 deadline for both VM-30 and AG 55 creates a bottleneck that requires advance planning, particularly for companies with multiple in-scope treaties.

Pricing and reinsurance actuaries should anticipate that AG 55 will influence treaty terms going forward. New transactions will increasingly include data-sharing provisions, change-in-law clauses, and reporting obligations designed to facilitate AG 55 compliance. The cost of AG 55 compliance may factor into reinsurance pricing as both cedants and reinsurers invest in the infrastructure needed to support ongoing disclosure.

Risk management actuaries at offshore reinsurers face a new set of demands from their U.S. counterparties. Providing data, supporting proxy asset development, and potentially preparing Similar Memorandum documentation are all new operational requirements that the AG 55 framework creates for assuming reinsurers.

The Actuarial Standards of Practice (ASOPs) that govern this work, particularly ASOP No. 22 (Statements of Actuarial Opinion Based on Asset Adequacy Analysis) and ASOP No. 7 (Analysis of Life, Health, or Property/Casualty Insurer Cash Flows), provide the professional framework within which AG 55 analysis must be conducted. Appointed actuaries should ensure their AG 55 work products are consistent with these standards, particularly in documenting assumptions, methodology, and the rationale for key judgments.

The Bottom Line

AG 55 is the most significant expansion of U.S. life insurance regulatory oversight in the past decade, and the first filing cycle has validated both the need for the guideline and the difficulty of implementing it. The disclosure-only approach was a pragmatic choice that allows regulators to calibrate future requirements based on actual data rather than theoretical concerns. But the direction of travel is clear: offshore reinsurance transactions will face increasing scrutiny, data requirements will tighten, and the possibility of prescriptive reserve requirements in 2027 is real.

For the roughly 100 companies that filed AG 55 reports by April 1, 2026, the first year was primarily about building infrastructure, establishing data pipelines, and making initial interpretive choices. Year two will be about refining those approaches based on regulatory feedback, moving to product-line granularity, and preparing for the possibility that disclosure alone will no longer be sufficient.

This continues a pattern that has been visible across the NAIC's approach to PE-affiliated life insurance oversight: start with transparency, build a data foundation, then layer on prescriptive requirements once the data supports informed rulemaking. Actuaries who are involved in offshore reinsurance transactions should treat the year-one filing not as a compliance exercise but as the first iteration of a process that will become progressively more demanding.